Comparison of voluntary adverse drug reaction reports and corresponding medical records

American Journal of Health-System Pharmacy

Volumn 60, Issue 6, 2003, Pages 572-575

  Troutman, William G ^a   Doherty, Kevin M ^b  

^a UNIVERSITY OF NEW MEXICO   (United States)

^b UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; OXYCODONE; PARACETAMOL;

ARTICLE; CLINICAL PRACTICE; DISEASE SEVERITY; DRUG INDUCED DISEASE; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; FEVER; HEALTH CARE ORGANIZATION; HEALTH PROGRAM; HOSPITAL PATIENT; HOSPITAL PHARMACY; HUMAN; INCIDENCE; MEDICAL DOCUMENTATION; MEDICAL RECORD; MEDICAL STAFF; PATIENT INFORMATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RASH; SELF REPORT; SYMPTOM; TECHNIQUE; COMPARATIVE STUDY; DRUG THERAPY; HEALTH SERVICES RESEARCH; PHARMACY AND THERAPEUTICS COMMITTEE; TEACHING HOSPITAL; UNITED STATES;

ADVERSE DRUG REACTION REPORTING SYSTEMS; DRUG THERAPY; HEALTH SERVICES RESEARCH; HOSPITALS, TEACHING; HUMANS; MEDICAL RECORDS; NEW MEXICO; PHARMACY AND THERAPEUTICS COMMITTEE;

EID: 0037444909     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/60.6.572     Document Type: Article

References (14)

1. Faich GA, Dreis M, Tomita D. National adverse drug reaction surveillance. 1986. Arch Intern Med. 1988; 148:785-7.
2. Saltiel E, Johnson E, Shane R. A team approach to adverse drug reaction surveillance: success at a tertiary care hospital. Hosp Formul. 1995; 39:226-8,231-2.
3. Tyler LS, Nickman NA. Hospital pharmacy compliance with JCAHO standards and ASHP guidelines for reporting adverse drug reactions. Am J Hosp Pharm. 1992; 49:845-50.
4. ASHP guidelines on adverse drug reaction monitoring and reporting. Am J Hosp Pharm. 1989; 46:336-7.
5. Jha AK, Kuperman GJ, Teich JM et al. Identifying adverse drug events: development of a computer-based monitor and comparison with chart review and stimulated voluntary report. J Am Med Inform Assoc. 1998; 5:305-14.
6. Bates DW, Leape LL, Petrycki S. Incidence and preventability of adverse drug events in hospitalized adults. J Gen Intern Med. 1993; 8:289-94.
7. Schumock GT, Thornton JP, Witte KW. Comparison of pharmacy-based concurrent surveillance and medical record retrospective reporting of adverse drug reactions. Am J Hosp Pharm. 1991; 48:1974-6.
8. Sivaram CA, Johnson S, Tirmizi SN et al. Morning report: a forum for reporting adverse drug reactions. Jt Comm J Qual Improv. 1996; 22:259-63.
9. Manasse HR Jr. Medication use in an imperfect world: drug misadventuring as an issue of public policy, part 1. Am J Hosp Pharm. 1989; 46:929-44.
10. Kelly WN. Can the frequency and risks of fatal adverse drug events be determined? Pharmacotherapy. 2001; 21:521-7.
11. International drug monitoring - the role of the hospital - a WHO report. Drug Intell Clin Pharm. 1970; 4:101-10.
12. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998; 279: 1200-5.
13. Fletcher AP. Spontaneous adverse drug reaction reporting vs. event monitoring: a comparison. J R Soc Med. 1991; 84:341-4.
14. O'Neil AC, Petersen LA, Cook EF et al. Physician reporting compared with medical-record review to identify adverse medical events. Ann Intern Med. 1993; 119:370-6.